background_1 background_2

CFCD meeting - December 16-17 2021 in PARIS

The meeting organised by the CFCD was rescheduled due to COVID19
It will take place in the Institut Necker Enfants Malades in PARIS form the 16 to 17th of December 2021.

Sanitary pass will be required for the participation to the meeting (Vaccination passport) or valid test results.

Click here for the final program and abstract book


Thursday December 16th, 2021

8:30 Opening of the registration desk

9:15 Welcome address

SESSION I – DC subsets
Chairpersons: Bénédicte Manoury and Marlène Dreux

9:30-9:55 Florent Ginhoux (France)
“The ever-expanding DC universe”?

10:00-10:25 Sophie Janssens (Belgium)
Dendritic cell maturation revisited

10:30-11:00 Coffee Break

11:00-11:25 Pierre Guermonprez (France)
DC subsets and T cell memory

11:30-12:15 Selected oral presentations

11:30-11:45 Stefanie Scheu (Germany)
The transcription factor BATF as novel regulator of type I interferon production in plasmacytoid dendritic cells

11:45-12:00 Andreas Schlitzer (Germany)
GPR183 dictates subtissular localisation of pulmonary CD301b+ conventional dendritic cells type 2 and instructs their survival via the TSLP – TSLP receptor axis

12:00-12:15 Javiera Villar (France)
ETV3 and ETV6 enable monocyte differentiation into dendritic cells during inflammation by repressing interferon-stimulated genes

12:15-12:45 Wolfgang Kastenmüller (Germany)
cDC1 maintain and guide the differentiation of TPEX cells in distinct cellular niches

12:45-15h30 LUNCH and Poster viewing

SESSION II – Tumor-associated macrophages and DCs
Chairpersons: Julie Helft and Paula Michea

15:30-15:55 Maria Casanova-Acebes (Spain)
Getting to know the origin of tumor-associated macrophages : challenges and opportunities for therapeutic intervention

16:00-16:25: Renato Ostuni (Italy)
Transcriptional control of tumor-associated macrophages

16:30-17:00 Selected oral presentations

16:30-16:45 Yohan Gerber-Ferder (France)
Breast cancer remotely remodel the hematopoietic niche favoring myelopoiesis and tumor growth

16:45-17:00 Margaux Huberti (France)
Spatial organization and prognostic impact of dendritic cell subsets in a large cohort of triple negative breast cancer patients

17:00-17:30 Kenneth Murphy (USA) videoconference
Genetic basis for divergence of DC progenitors[/I]

17:30 Cocktail

20:00 Speaker Dinner 

Friday December 17th 2021

9:00 Opening of the registration desk

SESSION III – DCs and macrophages in tissues
[i]Chairpersons: Héléna Païdassi and Jérôme Martin

9:30-9:55 Melanie Greter (Switzerland) visioconférence
Macrophage development and function

10:00-10:25 Juliana Idoyaga (USA)
Emerging dendritic cell heterogeneity: the in-betweens

10:30 Coffee Break

11:00-11:45 Selected oral presentations

11:00-11:15 Maria-Graciela Delgado (France)
Formation of the myeloid compartment in vivo: Revealing an unexpected role for the Arp2/3 complex

11:15-11:30 Zhana Haimon (Israël) videoconference
Microglia interactions with T cells in relapsing remitting EAE

11:30-11:45 Antonin Weckel (USA)
Early life interactions between commensal bacteria and dermal CD301b+ cDC2s facilitate long-term immune tolerance to the skin microbiome

11:45-12:15 Santiago Zelenay (United Kingdom) videoconference
Manipulating inflammation to unleash cancer immune control

12:15-14:30 LUNCH and Poster viewing

14:30-14:45 CFCD General Assembly

SESSION IV – DCs in diseases
Chairpersons: Sophie Laffont and Vanja Sisirak

14:45-15:10 Brian Ruffel (USA) videoconference
Therapeutic targeting of intratumoral dendritic cells

15:15-15:40 Stephanie Eisenbarth (USA) videoconference
Cellular mechanics of DC migration

15:45-16:15 Selected oral presentations

15:45-16:00 Elena Winheim (Germany)
Yellow fever vaccination induces distinct and overlapping gene expression programs in human blood DC and monocyte subsets

16:00-16:15 Lucie Maisonneuve (France)
Regulation of IRE1α, an ER stress sensor, in dendritic cells

16:15-16h40 Vanja Sisirak (France)
Plasmacytoid dendritic cells promote DNA autoreactivity

16:45-17:10 Marlène Dreux (France)
Severe COVID-19 patients have impaired plasmacytoid dendritic cell-mediated control of SARS-CoV-2-infected cells

17h15 Award ceremony and concluding remarks

17:30 End of the meeting